Citations are updated once a week. Recently added citations may not appear.
Context | Citation |
---|---|
Aspergillus flavus |
?
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Signal transduction and targeted therapy (Signal Transduct Target Ther ) Vol: 7 Issue 1 Pages: 143 Pub: 2022 Apr 29 Epub: 2022 Apr 29 Authors Wang B , Zhang L , Wang Y , Dai T , Qin Z , Zhou F , Zhang L , Publication |
Aspergillus flavus |
?
Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge. Gastroenterology (Gastroenterology ) Vol: 159 Issue 4 Pages: 1302-1310.e5 Pub: 2020 Oct Epub: 2020 Jun 26 Authors Zuo T , Zhan H , Zhang F , Liu Q , Tso EYK , Lui GCY , Chen N , Li A , Lu W , Chan FKL , Chan PKS , Ng SC , Publication |
Aspergillus flavus |
?
Gut Microbiome Alterations in COVID-19. Genomics, proteomics & bioinformatics (Genomics Proteomics Bioinformatics ) Vol: Issue Pages: Pub: 2021 Sep 21 Epub: 2021 Sep 21 Authors Zuo T , Wu X , Wen W , Lan P , Publication |
Aspergillus flavus |
?
Gut microbiota in COVID-19: new insights from inside. Gut microbes (Gut Microbes ) Vol: 15 Issue 1 Pages: 2201157 Pub: 2023 Jan-Dec Epub: Authors Zhou B , Pang X , Wu J , Liu T , Wang B , Cao H , Publication |
Aspergillus flavus |
?
Spices as Sustainable Food Preservatives: A Comprehensive Review of Their Antimicrobial Potential. Pharmaceuticals (Basel, Switzerland) (Pharmaceuticals (Basel) ) Vol: 16 Issue 10 Pages: Pub: 2023 Oct 12 Epub: 2023 Oct 12 Authors Sulieman AME , Abdallah EM , Alanazi NA , Ed-Dra A , Jamal A , Idriss H , Alshammari AS , Shommo SAM , Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.